Esker is favouring growth over a short-term margin boost. $ALESK Learn more in our recent update: hubs.ly/Q016Z8hD0

In this interview, Edison’s Ken Mestemacher speaks to Vection Technologies director and COO Gianmarco Orgnoni. Vection Technologies is a pioneer in the field of extended reality (#XR). Watch the full interview here: hubs.ly/Q016Z8hY0

Neil Shah took the opportunity to meet Amati Global Investors's Anna Macdonald. Anna and Neil talked about the invasion of Ukraine and how the Amati team is protecting clients’ capital as well as post-#Covid positioning of the team's diversified portfolio. hubs.ly/Q0175XQP0

We are pleased to announce that we recently initiated coverage on SenSen, an Australian-based company that applies artificial intelligence (#AI) to problems that involve monitoring physical spaces. Read the full initiation report here: hubs.ly/Q017jt7r0

@BokuPayByMobile's FY21 results reflect continued strong momentum in the Payments business and improved performance in the since-sold Identity business. $BOKU Read the latest Outlook here: hubs.ly/Q017pgbJ0

Following on from its positive early-March update, @Osirium confirms that strong order momentum continued to the end of Q122, resulting in a record bookings quarter. $OSI Read the update: hubs.ly/Q017rj8L0

Supply chain issues affecting the global coatings industry meant that although Applied Applied Graphene Materials (AGM) H122 revenues were similar to those in H121, they were below management expectations. $AGM Full update here: hubs.ly/Q017x23P0

In this interview BluGlass (ASX:BLG)'s executive chair James Walker discusses the company’s recent acquisition of a laser diode fabrication facility in California’s Silicon Valley. Watch the full video here: hubs.ly/Q017x6q30

FY21 was a record year for $4iG, with net revenues rising 62% y-o-y to HUF93bn and EBITDA rising 125% to HUF11.4bn, driven by a mix of organic growth and M&A. Read the update here: hubs.ly/Q017yd690

In this interview, Edison's Dan Ridsdale speaks to Dr Adrian Potts, CEO of Applied Graphene Materials, about the company's recent interim results, some of the applications is it working on and potential areas for growth. Watch the full video here: hubs.ly/Q017x6H_0

@WANdisco's Q122 trading update demonstrated that the momentum we reported on earlier this year has continued, with bookings and remaining performance obligations (RPO) up significantly $WAND Read the update: hubs.ly/Q017PSxT0

During the first eight months of FY22, Nanoco has begun to scale-up its programme to deliver nanomaterials to its major European customer. $NANO Read the update here: hubs.ly/Q01859SH0

XP Power Q122 trading update confirms demand has remained strong across the board, with order intake up 39% y-o-y. $XXP Read the update here:hubs.ly/Q0185fwz0

DiscoverIE continued to see strong order intake and sales in the remaining two months of FY22, closing the year ahead of board expectations. $DSCV Update here:hubs.ly/Q018l0xq0

Esker reported 18% y-o-y revenue growth for Q122 and continues to expect organic growth of 15–16% for the full year with operating margins in its target range of 12–15%. $ALESK Update here:hubs.ly/Q018xZgB0

With a 120% retention rate alongside an attractive investment opportunity that is currently undervalued against its peers, is this the time to take a closer look? Find out what every investor should know about this Edison client SenSen hubs.ly/Q018Bgb-0

@Osirium reported a relatively flat year for bookings and revenue in FY21, although this masks the doubling of the customer base over the year. . $OSI Full update here: hubs.ly/Q018Gst70

Doctor Care Anywhere Group’s Q122 results showed continuing revenue momentum from FY21, as well as a significant expansion in its gross margin as the costs of delivering consultations reverted to more normalised levels. $DOC Update here: hubs.ly/Q018RlJG0

centralnic has confirmed that revenue growth driven by Online Marketing continued at a very high level in Q122, with 51% organic revenue growth (LTM pro forma revenues of c US$530m). $CNIC Update here: hubs.ly/Q018T5yq0

The ultimate frontier for investors? 🔭 Why do Edison Research analysts think Mynaric is one to watch in 2022 and beyond? 🛰️ Stream now ➡️ hubs.ly/Q018PBXp0